Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, May 7, 2020 at 8:30 a.m. Eastern time to discuss its results for the first quarter ended March 31, 2020. A press release detailing the first quarter 2020 results will be issued prior to the call.
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has reported its financial results for the fourth quarter and full year ended December 31, 2019.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
CLXT earnings call for the period ending June 30, 2019.
Calyxt, Inc. (NASDAQ:CLXT) just released its latest quarterly report and things are not looking great. Earnings missed...
They have a low financial burden, which reduces the risk of loss for investors Continue reading...
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has licensed a new method to help increase plant gene editing efficiency from the University of Minnesota. The method has the potential to reduce the time needed to edit plants from approximately one year to several months.
Agriculture Operations Outlook: Tariffs to Mar Organic Gains
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has launched its new website to showcase how Calyxt is harnessing the ‘Power and Possibilities of Plants’.
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has reported its financial results for the first quarter ended March 31, 2020.
Calyxt (CLXT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Calyxt (CLXT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
Shares of Calyxt (NASDAQ:CLXT) were unchanged in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share were down 47.83% year over year to ($0.34), which missed the estimate of ($0.32).Revenue of $2,377,000 up by 1414.01% year over year, which missed the estimate of $4,060,000.Outlook Earnings guidance hasn't been issued by the company for now.Calyxt hasn't issued any revenue guidance for the time being.How To Listen To The Conference Call Date: May 07, 2020View more earnings on CLXTTime: 09:05 AM ETWebcast URL: https://viavid.webcasts.com/starthere.jsp?ei=1299871&tp_key=0b5db2d0d1Technicals 52-week high: $16.48Company's 52-week low was at $2.40Price action over last quarter: Up 5.02%Company Overview Calyxt Inc is an agricultural biotechnology company. It mainly engages in the development of food and agricultural business. The company develops and creates specialty food ingredients, such as oils and high fiber wheat, and food crops with desirable traits such as herbicide tolerance. It develops products such as reduced trans-fat soya oil, potato, gluten reduced wheat, and lower saturated fat canola oil. It generates all of its revenue from R&D contracts related to plant gene editing.See more from Benzinga * Recap: Albireo Pharma Q1 Earnings * Recap: International Seaways Q1 Earnings * Recap: Oaktree Specialty Lending Q2 Earnings(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has launched a retail offering of Calyno® cooking oil, the company’s first commercial product, a premium, high-performing oil, through the company’s newly launched e-commerce website calyno.com.
Calyxt, Inc.'s (NASDAQ:CLXT): Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops...
Tractor Supply (TSCO) benefits from its omni-channel efforts that include expansion of store base and technological advancements.
It is doubtless a positive to see that the Calyxt, Inc. (NASDAQ:CLXT) share price has gained some 55% in the last...
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. Cumulatively, through this week, it has been a 122% differential (up 52% for value vs up 174% for growth). This appears to be the longest and most severe drought for value […]